Mycobacterium tuberculosis puromycin hydrolase displays a prolyl oligopeptidase fold and an acyl aminopeptidase

YuanHao Zhao1, Qiaoli Feng1, Xiao Zhou2

  • 1Department of Biological Sciences, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu, China.

Proteins
|January 11, 2021
PubMed

Insights

Researchers determined the crystal structure of Mycobacterium tuberculosis puromycin hydrolase. This enzyme shows amino peptidase activity, preferring hydrophobic residues, and its structure aids in developing new therapeutic inhibitors.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Microbiology

Background:

  • Puromycin-hydrolizing peptidases belong to the prolyl oligopeptidase family, found across all life domains.
  • Homologs in Mycobacterium tuberculosis are poorly understood, despite their potential relevance.

Purpose of the Study:

  • To elucidate the structural and functional characteristics of a puromycin-hydrolizing peptidase from Mycobacterium tuberculosis.
  • To provide a structural basis for understanding enzyme activity and for developing targeted inhibitors.

Main Methods:

  • X-ray crystallography was used to determine the enzyme's structure at 3 Angstrom resolution.
  • Enzyme activity assays were performed to assess substrate specificity.

Main Results:

  • The crystal structure revealed a conserved prolyl oligopeptidase fold with alpha/beta-hydrolase and beta-propeller domains.
  • Distinctive loops were identified that limit access for larger substrates to the active site.
  • The enzyme exhibited amino peptidase activity, with a preference for hydrophobic residues like phenylalanine and leucine.

Conclusions:

  • The determined crystal structure of Mycobacterium tuberculosis puromycin hydrolase provides crucial insights into its fold and active site.
  • Understanding the enzyme's substrate specificity and structural features facilitates the rational design of therapeutic inhibitors.